Newsletter
Every new paper in this field, in your inbox.
In a study involving 990 liver resection patients, persistent acute kidney injury (AKI) was linked to significantly worse postoperative outcomes, including increased morbidity, extended hospital stays, and higher 90-day mortality rates. Among 384 patients with hepatocellular carcinoma, persistent AKI correlated with poorer overall survival, identified…
In a comparative study involving 96 patients, robot-assisted hemihepatectomy (rob-hh) demonstrated significant advantages over laparoscopic hemihepatectomy (lap-hh) via dorsal approach. Rob-hh resulted in reduced estimated blood loss (median: 100 ml vs. 300 ml), lower blood transfusion rates (4.9% vs. 29.1%), and fewer postoperative complications (26.8%…
A novel nomogram has been developed to predict postoperative survival in gallbladder cancer patients, incorporating eight critical factors including TNM stage and serum biomarkers. Performance metrics demonstrated consistent time-dependent concordance indices exceeding 0.70 and area under the curve surpassing 75% for 1-, 3-, and 5-year…
A comparison of laparoscopic hepatectomy (LH) and radiofrequency ablation (RFA) revealed that LH provides significantly better overall survival (OS) and disease-specific survival (DSS) for small hepatocellular carcinoma patients. In matched cohorts, 1, 3, and 5-year OS and DSS rates favored LH over RFA. For tumors…
Analysis of 10,977 patients with gastric adenocarcinoma and liver-only metastases revealed that those undergoing primary tumor resection combined with liver metastasectomy experienced significantly longer median overall survival (18.6 months) compared to non-surgical treatment (6.5 months). The study indicates that surgical resection, especially in highly selected…
A multicenter study involving 233 early-stage hepatocellular carcinoma patients revealed that microvascular invasion (MVI) grading significantly affects long-term outcomes post-laparoscopic liver resection. Specifically, median overall survival (OS) was 84.9 months for M0, 40.1 months for M1, and 25.2 months for M2. Likewise, recurrence-free survival (RFS)…
Treatment trends for locally advanced pancreatic cancer reveal that 67.67% of patients received primarily chemotherapy, with notable improvement in surgical resection rates over time. However, 41.19% also received radiation, yet many patients went untreated or did not receive guideline-recommended treatment (GRT). Socioeconomic factors like race,…
In a study involving 130 patients with unresectable colorectal cancer liver metastases, the use of contrast-enhanced intraoperative ultrasound (ce-ious) significantly improved hepatic recurrence-free survival rates compared to standard intraoperative ultrasound alone. Specifically, the ce-ious group demonstrated a lower recurrence rate (hazard ratio 0.55), especially in…
An analysis of 44,076 pancreatoduodenectomy patients reveals significant variability in the adoption and outcomes of minimally invasive pancreatoduodenectomy (mipd) across North America, Germany, the Netherlands, and Sweden. Usage rates of mipd ranged from 0.1% in Sweden to 17% in the Netherlands, with higher rates attributed…
Endoscopic ultrasound (EUS) demonstrated significant diagnostic yield for patients with unexplained common bile duct (CBD) dilation, particularly among those with negative prior imaging. In a cohort of 109 patients, 41 tested positive for various conditions, including choledocholithiasis and chronic pancreatitis. Factors such as older age…
